Global Olmesartan Medoxomil Tablets Market Growth 2024-2030

Report ID: 2972867 | Published Date: Mar 2026 | No. of Page: 140 | Base Year: 2025 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report

    1.1 Market Introduction

    1.2 Years Considered

    1.3 Research Objectives

    1.4 Market Research Methodology

    1.5 Research Process and Data Source

    1.6 Economic Indicators

    1.7 Currency Considered

    1.8 Market Estimation Caveats

2 Executive Summary

    2.1 World Market Overview

        2.1.1 Global Olmesartan Medoxomil Tablets Annual Sales 2019-2030

        2.1.2 World Current & Future Analysis for Olmesartan Medoxomil Tablets by Geographic Region, 2019, 2023 & 2030

        2.1.3 World Current & Future Analysis for Olmesartan Medoxomil Tablets by Country/Region, 2019, 2023 & 2030

    2.2 Olmesartan Medoxomil Tablets Segment by Type

        2.2.1 20mg

        2.2.2 40mg

        2.2.3 Others

    2.3 Olmesartan Medoxomil Tablets Sales by Type

        2.3.1 Global Olmesartan Medoxomil Tablets Sales Market Share by Type (2019-2024)

        2.3.2 Global Olmesartan Medoxomil Tablets Revenue and Market Share by Type (2019-2024)

        2.3.3 Global Olmesartan Medoxomil Tablets Sale Price by Type (2019-2024)

    2.4 Olmesartan Medoxomil Tablets Segment by Application

        2.4.1 Hospital and Clinic

        2.4.2 Pharmacy

    2.5 Olmesartan Medoxomil Tablets Sales by Application

        2.5.1 Global Olmesartan Medoxomil Tablets Sale Market Share by Application (2019-2024)

        2.5.2 Global Olmesartan Medoxomil Tablets Revenue and Market Share by Application (2019-2024)

        2.5.3 Global Olmesartan Medoxomil Tablets Sale Price by Application (2019-2024)

3 Global Olmesartan Medoxomil Tablets by Company

    3.1 Global Olmesartan Medoxomil Tablets Breakdown Data by Company

        3.1.1 Global Olmesartan Medoxomil Tablets Annual Sales by Company (2019-2024)

        3.1.2 Global Olmesartan Medoxomil Tablets Sales Market Share by Company (2019-2024)

    3.2 Global Olmesartan Medoxomil Tablets Annual Revenue by Company (2019-2024)

        3.2.1 Global Olmesartan Medoxomil Tablets Revenue by Company (2019-2024)

        3.2.2 Global Olmesartan Medoxomil Tablets Revenue Market Share by Company (2019-2024)

    3.3 Global Olmesartan Medoxomil Tablets Sale Price by Company

    3.4 Key Manufacturers Olmesartan Medoxomil Tablets Producing Area Distribution, Sales Area, Product Type

        3.4.1 Key Manufacturers Olmesartan Medoxomil Tablets Product Location Distribution

        3.4.2 Players Olmesartan Medoxomil Tablets Products Offered

    3.5 Market Concentration Rate Analysis

        3.5.1 Competition Landscape Analysis

        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    3.6 New Products and Potential Entrants

    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Olmesartan Medoxomil Tablets by Geographic Region

    4.1 World Historic Olmesartan Medoxomil Tablets Market Size by Geographic Region (2019-2024)

        4.1.1 Global Olmesartan Medoxomil Tablets Annual Sales by Geographic Region (2019-2024)

        4.1.2 Global Olmesartan Medoxomil Tablets Annual Revenue by Geographic Region (2019-2024)

    4.2 World Historic Olmesartan Medoxomil Tablets Market Size by Country/Region (2019-2024)

        4.2.1 Global Olmesartan Medoxomil Tablets Annual Sales by Country/Region (2019-2024)

        4.2.2 Global Olmesartan Medoxomil Tablets Annual Revenue by Country/Region (2019-2024)

    4.3 Americas Olmesartan Medoxomil Tablets Sales Growth

    4.4 APAC Olmesartan Medoxomil Tablets Sales Growth

    4.5 Europe Olmesartan Medoxomil Tablets Sales Growth

    4.6 Middle East & Africa Olmesartan Medoxomil Tablets Sales Growth

5 Americas

    5.1 Americas Olmesartan Medoxomil Tablets Sales by Country

        5.1.1 Americas Olmesartan Medoxomil Tablets Sales by Country (2019-2024)

        5.1.2 Americas Olmesartan Medoxomil Tablets Revenue by Country (2019-2024)

    5.2 Americas Olmesartan Medoxomil Tablets Sales by Type

    5.3 Americas Olmesartan Medoxomil Tablets Sales by Application

    5.4 United States

    5.5 Canada

    5.6 Mexico

    5.7 Brazil

6 APAC

    6.1 APAC Olmesartan Medoxomil Tablets Sales by Region

        6.1.1 APAC Olmesartan Medoxomil Tablets Sales by Region (2019-2024)

        6.1.2 APAC Olmesartan Medoxomil Tablets Revenue by Region (2019-2024)

    6.2 APAC Olmesartan Medoxomil Tablets Sales by Type

    6.3 APAC Olmesartan Medoxomil Tablets Sales by Application

    6.4 China

    6.5 Japan

    6.6 South Korea

    6.7 Southeast Asia

    6.8 India

    6.9 Australia

    6.10 China Taiwan

7 Europe

    7.1 Europe Olmesartan Medoxomil Tablets by Country

        7.1.1 Europe Olmesartan Medoxomil Tablets Sales by Country (2019-2024)

        7.1.2 Europe Olmesartan Medoxomil Tablets Revenue by Country (2019-2024)

    7.2 Europe Olmesartan Medoxomil Tablets Sales by Type

    7.3 Europe Olmesartan Medoxomil Tablets Sales by Application

    7.4 Germany

    7.5 France

    7.6 UK

    7.7 Italy

    7.8 Russia

8 Middle East & Africa

    8.1 Middle East & Africa Olmesartan Medoxomil Tablets by Country

        8.1.1 Middle East & Africa Olmesartan Medoxomil Tablets Sales by Country (2019-2024)

        8.1.2 Middle East & Africa Olmesartan Medoxomil Tablets Revenue by Country (2019-2024)

    8.2 Middle East & Africa Olmesartan Medoxomil Tablets Sales by Type

    8.3 Middle East & Africa Olmesartan Medoxomil Tablets Sales by Application

    8.4 Egypt

    8.5 South Africa

    8.6 Israel

    8.7 Turkey

    8.8 GCC Countries

9 Market Drivers, Challenges and Trends

    9.1 Market Drivers & Growth Opportunities

    9.2 Market Challenges & Risks

    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

    10.1 Raw Material and Suppliers

    10.2 Manufacturing Cost Structure Analysis of Olmesartan Medoxomil Tablets

    10.3 Manufacturing Process Analysis of Olmesartan Medoxomil Tablets

    10.4 Industry Chain Structure of Olmesartan Medoxomil Tablets

11 Marketing, Distributors and Customer

    11.1 Sales Channel

        11.1.1 Direct Channels

        11.1.2 Indirect Channels

    11.2 Olmesartan Medoxomil Tablets Distributors

    11.3 Olmesartan Medoxomil Tablets Customer

12 World Forecast Review for Olmesartan Medoxomil Tablets by Geographic Region

    12.1 Global Olmesartan Medoxomil Tablets Market Size Forecast by Region

        12.1.1 Global Olmesartan Medoxomil Tablets Forecast by Region (2025-2030)

        12.1.2 Global Olmesartan Medoxomil Tablets Annual Revenue Forecast by Region (2025-2030)

    12.2 Americas Forecast by Country

    12.3 APAC Forecast by Region

    12.4 Europe Forecast by Country

    12.5 Middle East & Africa Forecast by Country

    12.6 Global Olmesartan Medoxomil Tablets Forecast by Type

    12.7 Global Olmesartan Medoxomil Tablets Forecast by Application

13 Key Players Analysis

    13.1 Daiichi Sankyo

        13.1.1 Daiichi Sankyo Company Information

        13.1.2 Daiichi Sankyo Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.1.3 Daiichi Sankyo Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.1.4 Daiichi Sankyo Main Business Overview

        13.1.5 Daiichi Sankyo Latest Developments

    13.2 Teva Pharmaceutical

        13.2.1 Teva Pharmaceutical Company Information

        13.2.2 Teva Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.2.3 Teva Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.2.4 Teva Pharmaceutical Main Business Overview

        13.2.5 Teva Pharmaceutical Latest Developments

    13.3 Glenmark Pharmaceuticals

        13.3.1 Glenmark Pharmaceuticals Company Information

        13.3.2 Glenmark Pharmaceuticals Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.3.3 Glenmark Pharmaceuticals Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.3.4 Glenmark Pharmaceuticals Main Business Overview

        13.3.5 Glenmark Pharmaceuticals Latest Developments

    13.4 Biocon

        13.4.1 Biocon Company Information

        13.4.2 Biocon Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.4.3 Biocon Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.4.4 Biocon Main Business Overview

        13.4.5 Biocon Latest Developments

    13.5 Lupin

        13.5.1 Lupin Company Information

        13.5.2 Lupin Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.5.3 Lupin Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.5.4 Lupin Main Business Overview

        13.5.5 Lupin Latest Developments

    13.6 Sun Pharmaceutical

        13.6.1 Sun Pharmaceutical Company Information

        13.6.2 Sun Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.6.3 Sun Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.6.4 Sun Pharmaceutical Main Business Overview

        13.6.5 Sun Pharmaceutical Latest Developments

    13.7 Mylan

        13.7.1 Mylan Company Information

        13.7.2 Mylan Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.7.3 Mylan Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.7.4 Mylan Main Business Overview

        13.7.5 Mylan Latest Developments

    13.8 CR Double-Crane

        13.8.1 CR Double-Crane Company Information

        13.8.2 CR Double-Crane Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.8.3 CR Double-Crane Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.8.4 CR Double-Crane Main Business Overview

        13.8.5 CR Double-Crane Latest Developments

    13.9 Beijing Foyou Pharmaceutical

        13.9.1 Beijing Foyou Pharmaceutical Company Information

        13.9.2 Beijing Foyou Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.9.3 Beijing Foyou Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.9.4 Beijing Foyou Pharmaceutical Main Business Overview

        13.9.5 Beijing Foyou Pharmaceutical Latest Developments

    13.10 Zhejiang NuoDe Pharmaceutical

        13.10.1 Zhejiang NuoDe Pharmaceutical Company Information

        13.10.2 Zhejiang NuoDe Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.10.3 Zhejiang NuoDe Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.10.4 Zhejiang NuoDe Pharmaceutical Main Business Overview

        13.10.5 Zhejiang NuoDe Pharmaceutical Latest Developments

    13.11 Chongqing Kerui Pharmaceutical

        13.11.1 Chongqing Kerui Pharmaceutical Company Information

        13.11.2 Chongqing Kerui Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.11.3 Chongqing Kerui Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.11.4 Chongqing Kerui Pharmaceutical Main Business Overview

        13.11.5 Chongqing Kerui Pharmaceutical Latest Developments

    13.12 Bright Future Pharmaceutical

        13.12.1 Bright Future Pharmaceutical Company Information

        13.12.2 Bright Future Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.12.3 Bright Future Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.12.4 Bright Future Pharmaceutical Main Business Overview

        13.12.5 Bright Future Pharmaceutical Latest Developments

    13.13 Buchang Pharma

        13.13.1 Buchang Pharma Company Information

        13.13.2 Buchang Pharma Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.13.3 Buchang Pharma Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.13.4 Buchang Pharma Main Business Overview

        13.13.5 Buchang Pharma Latest Developments

    13.14 Qilu Pharmaceutical

        13.14.1 Qilu Pharmaceutical Company Information

        13.14.2 Qilu Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.14.3 Qilu Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.14.4 Qilu Pharmaceutical Main Business Overview

        13.14.5 Qilu Pharmaceutical Latest Developments

    13.15 Chia Tai-Tianqing Pharmaceutical

        13.15.1 Chia Tai-Tianqing Pharmaceutical Company Information

        13.15.2 Chia Tai-Tianqing Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.15.3 Chia Tai-Tianqing Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.15.4 Chia Tai-Tianqing Pharmaceutical Main Business Overview

        13.15.5 Chia Tai-Tianqing Pharmaceutical Latest Developments

    13.16 Shenzhen Salubris Pharmaceuticals

        13.16.1 Shenzhen Salubris Pharmaceuticals Company Information

        13.16.2 Shenzhen Salubris Pharmaceuticals Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.16.3 Shenzhen Salubris Pharmaceuticals Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.16.4 Shenzhen Salubris Pharmaceuticals Main Business Overview

        13.16.5 Shenzhen Salubris Pharmaceuticals Latest Developments

    13.17 Chengdu Brilliant Pharmaceutical

        13.17.1 Chengdu Brilliant Pharmaceutical Company Information

        13.17.2 Chengdu Brilliant Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.17.3 Chengdu Brilliant Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.17.4 Chengdu Brilliant Pharmaceutical Main Business Overview

        13.17.5 Chengdu Brilliant Pharmaceutical Latest Developments

    13.18 Zhuhai Rundu Pharmaceutical

        13.18.1 Zhuhai Rundu Pharmaceutical Company Information

        13.18.2 Zhuhai Rundu Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

        13.18.3 Zhuhai Rundu Pharmaceutical Olmesartan Medoxomil Tablets Sales, Revenue, Price and Gross Margin (2019-2024)

        13.18.4 Zhuhai Rundu Pharmaceutical Main Business Overview

        13.18.5 Zhuhai Rundu Pharmaceutical Latest Developments

14 Research Findings and Conclusion


List of Tables

    Table 1. Olmesartan Medoxomil Tablets Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Olmesartan Medoxomil Tablets Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of 20mg

    Table 4. Major Players of 40mg

    Table 5. Major Players of Others

    Table 6. Global Olmesartan Medoxomil Tablets Sales by Type (2019-2024) & (K Units)

    Table 7. Global Olmesartan Medoxomil Tablets Sales Market Share by Type (2019-2024)

    Table 8. Global Olmesartan Medoxomil Tablets Revenue by Type (2019-2024) & ($ million)

    Table 9. Global Olmesartan Medoxomil Tablets Revenue Market Share by Type (2019-2024)

    Table 10. Global Olmesartan Medoxomil Tablets Sale Price by Type (2019-2024) & (US$/Unit)

    Table 11. Global Olmesartan Medoxomil Tablets Sales by Application (2019-2024) & (K Units)

    Table 12. Global Olmesartan Medoxomil Tablets Sales Market Share by Application (2019-2024)

    Table 13. Global Olmesartan Medoxomil Tablets Revenue by Application (2019-2024)

    Table 14. Global Olmesartan Medoxomil Tablets Revenue Market Share by Application (2019-2024)

    Table 15. Global Olmesartan Medoxomil Tablets Sale Price by Application (2019-2024) & (US$/Unit)

    Table 16. Global Olmesartan Medoxomil Tablets Sales by Company (2019-2024) & (K Units)

    Table 17. Global Olmesartan Medoxomil Tablets Sales Market Share by Company (2019-2024)

    Table 18. Global Olmesartan Medoxomil Tablets Revenue by Company (2019-2024) ($ Millions)

    Table 19. Global Olmesartan Medoxomil Tablets Revenue Market Share by Company (2019-2024)

    Table 20. Global Olmesartan Medoxomil Tablets Sale Price by Company (2019-2024) & (US$/Unit)

    Table 21. Key Manufacturers Olmesartan Medoxomil Tablets Producing Area Distribution and Sales Area

    Table 22. Players Olmesartan Medoxomil Tablets Products Offered

    Table 23. Olmesartan Medoxomil Tablets Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 24. New Products and Potential Entrants

    Table 25. Mergers & Acquisitions, Expansion

    Table 26. Global Olmesartan Medoxomil Tablets Sales by Geographic Region (2019-2024) & (K Units)

    Table 27. Global Olmesartan Medoxomil Tablets Sales Market Share Geographic Region (2019-2024)

    Table 28. Global Olmesartan Medoxomil Tablets Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 29. Global Olmesartan Medoxomil Tablets Revenue Market Share by Geographic Region (2019-2024)

    Table 30. Global Olmesartan Medoxomil Tablets Sales by Country/Region (2019-2024) & (K Units)

    Table 31. Global Olmesartan Medoxomil Tablets Sales Market Share by Country/Region (2019-2024)

    Table 32. Global Olmesartan Medoxomil Tablets Revenue by Country/Region (2019-2024) & ($ millions)

    Table 33. Global Olmesartan Medoxomil Tablets Revenue Market Share by Country/Region (2019-2024)

    Table 34. Americas Olmesartan Medoxomil Tablets Sales by Country (2019-2024) & (K Units)

    Table 35. Americas Olmesartan Medoxomil Tablets Sales Market Share by Country (2019-2024)

    Table 36. Americas Olmesartan Medoxomil Tablets Revenue by Country (2019-2024) & ($ Millions)

    Table 37. Americas Olmesartan Medoxomil Tablets Revenue Market Share by Country (2019-2024)

    Table 38. Americas Olmesartan Medoxomil Tablets Sales by Type (2019-2024) & (K Units)

    Table 39. Americas Olmesartan Medoxomil Tablets Sales by Application (2019-2024) & (K Units)

    Table 40. APAC Olmesartan Medoxomil Tablets Sales by Region (2019-2024) & (K Units)

    Table 41. APAC Olmesartan Medoxomil Tablets Sales Market Share by Region (2019-2024)

    Table 42. APAC Olmesartan Medoxomil Tablets Revenue by Region (2019-2024) & ($ Millions)

    Table 43. APAC Olmesartan Medoxomil Tablets Revenue Market Share by Region (2019-2024)

    Table 44. APAC Olmesartan Medoxomil Tablets Sales by Type (2019-2024) & (K Units)

    Table 45. APAC Olmesartan Medoxomil Tablets Sales by Application (2019-2024) & (K Units)

    Table 46. Europe Olmesartan Medoxomil Tablets Sales by Country (2019-2024) & (K Units)

    Table 47. Europe Olmesartan Medoxomil Tablets Sales Market Share by Country (2019-2024)

    Table 48. Europe Olmesartan Medoxomil Tablets Revenue by Country (2019-2024) & ($ Millions)

    Table 49. Europe Olmesartan Medoxomil Tablets Revenue Market Share by Country (2019-2024)

    Table 50. Europe Olmesartan Medoxomil Tablets Sales by Type (2019-2024) & (K Units)

    Table 51. Europe Olmesartan Medoxomil Tablets Sales by Application (2019-2024) & (K Units)

    Table 52. Middle East & Africa Olmesartan Medoxomil Tablets Sales by Country (2019-2024) & (K Units)

    Table 53. Middle East & Africa Olmesartan Medoxomil Tablets Sales Market Share by Country (2019-2024)

    Table 54. Middle East & Africa Olmesartan Medoxomil Tablets Revenue by Country (2019-2024) & ($ Millions)

    Table 55. Middle East & Africa Olmesartan Medoxomil Tablets Revenue Market Share by Country (2019-2024)

    Table 56. Middle East & Africa Olmesartan Medoxomil Tablets Sales by Type (2019-2024) & (K Units)

    Table 57. Middle East & Africa Olmesartan Medoxomil Tablets Sales by Application (2019-2024) & (K Units)

    Table 58. Key Market Drivers & Growth Opportunities of Olmesartan Medoxomil Tablets

    Table 59. Key Market Challenges & Risks of Olmesartan Medoxomil Tablets

    Table 60. Key Industry Trends of Olmesartan Medoxomil Tablets

    Table 61. Olmesartan Medoxomil Tablets Raw Material

    Table 62. Key Suppliers of Raw Materials

    Table 63. Olmesartan Medoxomil Tablets Distributors List

    Table 64. Olmesartan Medoxomil Tablets Customer List

    Table 65. Global Olmesartan Medoxomil Tablets Sales Forecast by Region (2025-2030) & (K Units)

    Table 66. Global Olmesartan Medoxomil Tablets Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 67. Americas Olmesartan Medoxomil Tablets Sales Forecast by Country (2025-2030) & (K Units)

    Table 68. Americas Olmesartan Medoxomil Tablets Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 69. APAC Olmesartan Medoxomil Tablets Sales Forecast by Region (2025-2030) & (K Units)

    Table 70. APAC Olmesartan Medoxomil Tablets Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 71. Europe Olmesartan Medoxomil Tablets Sales Forecast by Country (2025-2030) & (K Units)

    Table 72. Europe Olmesartan Medoxomil Tablets Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 73. Middle East & Africa Olmesartan Medoxomil Tablets Sales Forecast by Country (2025-2030) & (K Units)

    Table 74. Middle East & Africa Olmesartan Medoxomil Tablets Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 75. Global Olmesartan Medoxomil Tablets Sales Forecast by Type (2025-2030) & (K Units)

    Table 76. Global Olmesartan Medoxomil Tablets Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 77. Global Olmesartan Medoxomil Tablets Sales Forecast by Application (2025-2030) & (K Units)

    Table 78. Global Olmesartan Medoxomil Tablets Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 79. Daiichi Sankyo Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 80. Daiichi Sankyo Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 81. Daiichi Sankyo Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 82. Daiichi Sankyo Main Business

    Table 83. Daiichi Sankyo Latest Developments

    Table 84. Teva Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 85. Teva Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 86. Teva Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 87. Teva Pharmaceutical Main Business

    Table 88. Teva Pharmaceutical Latest Developments

    Table 89. Glenmark Pharmaceuticals Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 90. Glenmark Pharmaceuticals Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 91. Glenmark Pharmaceuticals Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 92. Glenmark Pharmaceuticals Main Business

    Table 93. Glenmark Pharmaceuticals Latest Developments

    Table 94. Biocon Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 95. Biocon Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 96. Biocon Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 97. Biocon Main Business

    Table 98. Biocon Latest Developments

    Table 99. Lupin Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 100. Lupin Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 101. Lupin Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 102. Lupin Main Business

    Table 103. Lupin Latest Developments

    Table 104. Sun Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 105. Sun Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 106. Sun Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 107. Sun Pharmaceutical Main Business

    Table 108. Sun Pharmaceutical Latest Developments

    Table 109. Mylan Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 110. Mylan Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 111. Mylan Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 112. Mylan Main Business

    Table 113. Mylan Latest Developments

    Table 114. CR Double-Crane Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 115. CR Double-Crane Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 116. CR Double-Crane Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 117. CR Double-Crane Main Business

    Table 118. CR Double-Crane Latest Developments

    Table 119. Beijing Foyou Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 120. Beijing Foyou Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 121. Beijing Foyou Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 122. Beijing Foyou Pharmaceutical Main Business

    Table 123. Beijing Foyou Pharmaceutical Latest Developments

    Table 124. Zhejiang NuoDe Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 125. Zhejiang NuoDe Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 126. Zhejiang NuoDe Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 127. Zhejiang NuoDe Pharmaceutical Main Business

    Table 128. Zhejiang NuoDe Pharmaceutical Latest Developments

    Table 129. Chongqing Kerui Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 130. Chongqing Kerui Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 131. Chongqing Kerui Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 132. Chongqing Kerui Pharmaceutical Main Business

    Table 133. Chongqing Kerui Pharmaceutical Latest Developments

    Table 134. Bright Future Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 135. Bright Future Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 136. Bright Future Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 137. Bright Future Pharmaceutical Main Business

    Table 138. Bright Future Pharmaceutical Latest Developments

    Table 139. Buchang Pharma Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 140. Buchang Pharma Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 141. Buchang Pharma Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 142. Buchang Pharma Main Business

    Table 143. Buchang Pharma Latest Developments

    Table 144. Qilu Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 145. Qilu Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 146. Qilu Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 147. Qilu Pharmaceutical Main Business

    Table 148. Qilu Pharmaceutical Latest Developments

    Table 149. Chia Tai-Tianqing Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 150. Chia Tai-Tianqing Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 151. Chia Tai-Tianqing Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 152. Chia Tai-Tianqing Pharmaceutical Main Business

    Table 153. Chia Tai-Tianqing Pharmaceutical Latest Developments

    Table 154. Shenzhen Salubris Pharmaceuticals Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 155. Shenzhen Salubris Pharmaceuticals Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 156. Shenzhen Salubris Pharmaceuticals Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 157. Shenzhen Salubris Pharmaceuticals Main Business

    Table 158. Shenzhen Salubris Pharmaceuticals Latest Developments

    Table 159. Chengdu Brilliant Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 160. Chengdu Brilliant Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 161. Chengdu Brilliant Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 162. Chengdu Brilliant Pharmaceutical Main Business

    Table 163. Chengdu Brilliant Pharmaceutical Latest Developments

    Table 164. Zhuhai Rundu Pharmaceutical Basic Information, Olmesartan Medoxomil Tablets Manufacturing Base, Sales Area and Its Competitors

    Table 165. Zhuhai Rundu Pharmaceutical Olmesartan Medoxomil Tablets Product Portfolios and Specifications

    Table 166. Zhuhai Rundu Pharmaceutical Olmesartan Medoxomil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 167. Zhuhai Rundu Pharmaceutical Main Business

    Table 168. Zhuhai Rundu Pharmaceutical Latest Developments

List of Figures

    Figure 1. Picture of Olmesartan Medoxomil Tablets

    Figure 2. Olmesartan Medoxomil Tablets Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Olmesartan Medoxomil Tablets Sales Growth Rate 2019-2030 (K Units)

    Figure 7. Global Olmesartan Medoxomil Tablets Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Olmesartan Medoxomil Tablets Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of 20mg

    Figure 10. Product Picture of 40mg

    Figure 11. Product Picture of Others

    Figure 12. Global Olmesartan Medoxomil Tablets Sales Market Share by Type in 2023

    Figure 13. Global Olmesartan Medoxomil Tablets Revenue Market Share by Type (2019-2024)

    Figure 14. Olmesartan Medoxomil Tablets Consumed in Hospital and Clinic

    Figure 15. Global Olmesartan Medoxomil Tablets Market: Hospital and Clinic (2019-2024) & (K Units)

    Figure 16. Olmesartan Medoxomil Tablets Consumed in Pharmacy

    Figure 17. Global Olmesartan Medoxomil Tablets Market: Pharmacy (2019-2024) & (K Units)

    Figure 18. Global Olmesartan Medoxomil Tablets Sales Market Share by Application (2023)

    Figure 19. Global Olmesartan Medoxomil Tablets Revenue Market Share by Application in 2023

    Figure 20. Olmesartan Medoxomil Tablets Sales Market by Company in 2023 (K Units)

    Figure 21. Global Olmesartan Medoxomil Tablets Sales Market Share by Company in 2023

    Figure 22. Olmesartan Medoxomil Tablets Revenue Market by Company in 2023 ($ Million)

    Figure 23. Global Olmesartan Medoxomil Tablets Revenue Market Share by Company in 2023

    Figure 24. Global Olmesartan Medoxomil Tablets Sales Market Share by Geographic Region (2019-2024)

    Figure 25. Global Olmesartan Medoxomil Tablets Revenue Market Share by Geographic Region in 2023

    Figure 26. Americas Olmesartan Medoxomil Tablets Sales 2019-2024 (K Units)

    Figure 27. Americas Olmesartan Medoxomil Tablets Revenue 2019-2024 ($ Millions)

    Figure 28. APAC Olmesartan Medoxomil Tablets Sales 2019-2024 (K Units)

    Figure 29. APAC Olmesartan Medoxomil Tablets Revenue 2019-2024 ($ Millions)

    Figure 30. Europe Olmesartan Medoxomil Tablets Sales 2019-2024 (K Units)

    Figure 31. Europe Olmesartan Medoxomil Tablets Revenue 2019-2024 ($ Millions)

    Figure 32. Middle East & Africa Olmesartan Medoxomil Tablets Sales 2019-2024 (K Units)

    Figure 33. Middle East & Africa Olmesartan Medoxomil Tablets Revenue 2019-2024 ($ Millions)

    Figure 34. Americas Olmesartan Medoxomil Tablets Sales Market Share by Country in 2023

    Figure 35. Americas Olmesartan Medoxomil Tablets Revenue Market Share by Country in 2023

    Figure 36. Americas Olmesartan Medoxomil Tablets Sales Market Share by Type (2019-2024)

    Figure 37. Americas Olmesartan Medoxomil Tablets Sales Market Share by Application (2019-2024)

    Figure 38. United States Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 39. Canada Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 40. Mexico Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 41. Brazil Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 42. APAC Olmesartan Medoxomil Tablets Sales Market Share by Region in 2023

    Figure 43. APAC Olmesartan Medoxomil Tablets Revenue Market Share by Regions in 2023

    Figure 44. APAC Olmesartan Medoxomil Tablets Sales Market Share by Type (2019-2024)

    Figure 45. APAC Olmesartan Medoxomil Tablets Sales Market Share by Application (2019-2024)

    Figure 46. China Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 47. Japan Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 48. South Korea Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 49. Southeast Asia Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 50. India Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 51. Australia Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 52. China Taiwan Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 53. Europe Olmesartan Medoxomil Tablets Sales Market Share by Country in 2023

    Figure 54. Europe Olmesartan Medoxomil Tablets Revenue Market Share by Country in 2023

    Figure 55. Europe Olmesartan Medoxomil Tablets Sales Market Share by Type (2019-2024)

    Figure 56. Europe Olmesartan Medoxomil Tablets Sales Market Share by Application (2019-2024)

    Figure 57. Germany Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 58. France Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 59. UK Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 60. Italy Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 61. Russia Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 62. Middle East & Africa Olmesartan Medoxomil Tablets Sales Market Share by Country in 2023

    Figure 63. Middle East & Africa Olmesartan Medoxomil Tablets Revenue Market Share by Country in 2023

    Figure 64. Middle East & Africa Olmesartan Medoxomil Tablets Sales Market Share by Type (2019-2024)

    Figure 65. Middle East & Africa Olmesartan Medoxomil Tablets Sales Market Share by Application (2019-2024)

    Figure 66. Egypt Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 67. South Africa Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 68. Israel Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 69. Turkey Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 70. GCC Country Olmesartan Medoxomil Tablets Revenue Growth 2019-2024 ($ Millions)

    Figure 71. Manufacturing Cost Structure Analysis of Olmesartan Medoxomil Tablets in 2023

    Figure 72. Manufacturing Process Analysis of Olmesartan Medoxomil Tablets

    Figure 73. Industry Chain Structure of Olmesartan Medoxomil Tablets

    Figure 74. Channels of Distribution

    Figure 75. Global Olmesartan Medoxomil Tablets Sales Market Forecast by Region (2025-2030)

    Figure 76. Global Olmesartan Medoxomil Tablets Revenue Market Share Forecast by Region (2025-2030)

    Figure 77. Global Olmesartan Medoxomil Tablets Sales Market Share Forecast by Type (2025-2030)

    Figure 78. Global Olmesartan Medoxomil Tablets Revenue Market Share Forecast by Type (2025-2030)

    Figure 79. Global Olmesartan Medoxomil Tablets Sales Market Share Forecast by Application (2025-2030)

    Figure 80. Global Olmesartan Medoxomil Tablets Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Daiichi Sankyo"|||"Teva Pharmaceutical"|||"Glenmark Pharmaceuticals"|||"Biocon"|||"Lupin"|||"Sun Pharmaceutical"|||"Mylan"|||"CR Double-Crane"|||"Beijing Foyou Pharmaceutical"|||"Zhejiang NuoDe Pharmaceutical"|||"Chongqing Kerui Pharmaceutical"|||"Bright Future Pharmaceutical"|||"Buchang Pharma"|||"Qilu Pharmaceutical"|||"Chia Tai-Tianqing Pharmaceutical"|||"Shenzhen Salubris Pharmaceuticals"|||"Chengdu Brilliant Pharmaceutical"|||"Zhuhai Rundu Pharmaceutical"
Frequently Asked Questions
Olmesartan Medoxomil Tablets report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Olmesartan Medoxomil Tablets report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Olmesartan Medoxomil Tablets report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports